carmustine with propylene glycol formulation vi-0609
Generic: Carmustine with Propylene Glycol Formulation VI-0609
carmustine with propylene glycol formulation vi-0609: 1 clinical trial tracked.
carmustine with propylene glycol formulation vi-0609 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about carmustine with propylene glycol formulation vi-0609, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)
Primary endpoint: Evaluation of infusion-related toxicities
InterventionalRandomizedopen49 targetStarted 2025-03Completion 2027-044 sites · United StatesVIVUS LLC